| Breakdown | Dec 2025 | Mar 2025 | Dec 2023 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 392.96M | 343.38M | 301.43M | 305.11M | 290.21M |
| Gross Profit | 131.88M | 114.08M | 115.94M | 121.85M | 97.06M |
| EBITDA | 62.04M | 61.85M | 59.30M | 76.27M | 57.12M |
| Net Income | 39.49M | 26.98M | 19.21M | 50.64M | 21.84M |
Balance Sheet | |||||
| Total Assets | 521.73M | 457.73M | 353.94M | 328.19M | 309.33M |
| Cash, Cash Equivalents and Short-Term Investments | 8.36M | 69.62M | 20.62M | 6.44M | 4.42M |
| Total Debt | 93.70M | 100.13M | 105.92M | 108.35M | 243.56M |
| Total Liabilities | 351.69M | 324.29M | 249.51M | 257.88M | 394.58M |
| Stockholders Equity | 170.04M | 133.44M | 104.44M | 70.31M | -85.25M |
Cash Flow | |||||
| Free Cash Flow | -2.36M | 78.37M | -13.97M | 34.84M | 37.62M |
| Operating Cash Flow | 20.36M | 100.51M | 8.40M | 54.80M | 56.48M |
| Investing Cash Flow | -22.09M | -30.76M | -19.78M | -10.88M | -28.29M |
| Financing Cash Flow | -19.57M | -19.77M | -5.27M | -54.74M | -15.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | €112.95M | 2.92 | ― | 3.76% | 2.09% | 46.00% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | €3.05B | 5.99 | 13.55% | 0.74% | -2.57% | 39.27% | |
59 Neutral | €1.24B | 26.70 | ― | 0.14% | 14.44% | 41.17% | |
49 Neutral | €487.51M | -9.57 | -12.90% | ― | 7.63% | 25.06% | |
43 Neutral | €189.56M | -1.98 | -22.05% | ― | 7.21% | 47.92% |